Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2025-12-24 @ 6:35 PM
NCT ID:
NCT03652857
Eligibility Criteria:
Inclusion Criteria:
* 18，Pathologically proven non small cell lung cancer
* Adenocarcinoma，No-drive gene mutaion (EGFR、ALK、ROS1） by NGS
* Squamous cell carcinoma，no gene detection
* Progress after second line
* PS score \>2
Exclusion Criteria:
* Patients received apatinib or Vinorelbine treatment before
* EGFR, ALK or ROS1 mutation
* Patients with contraindication of chemotherapy
* Pregnant or breast feeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03652857
Study Brief:
Protocol Section:
NCT03652857